TY  - JOUR
AU  - Paez-Vega, Aurora
AU  - Cantisan, Sara
AU  - Vaquero, Jose Manuel
AU  - Vidal, Elisa
AU  - Luque-Pineda, Antonio
AU  - Lobo-Acosta, Maria Angeles
AU  - Perez, Ana Belen
AU  - Alonso-Moralejo, Rodrigo
AU  - Iturbe, David
AU  - Monforte, Victor
AU  - Otero-Gonzalez, Isabel
AU  - Pastor, Amparo
AU  - Ussetti, Piedad
AU  - Torre-Cisneros, Julian
PY  - 2019
DO  - 10.1136/bmjopen-2019-030648
UR  - http://hdl.handle.net/10668/14405
T2  - BMJ open
AB  - Prolonged use of antivirals to prevent the development of cytomegalovirus (CMV) disease in lung transplant patients has been shown to have significant side effects, for which alternatives are being sought to reduce their use. The monitoring of cell...
LA  - en
PB  - BMJ Open
KW  - Cytomegalovirus
KW  - Immuno-guided prophylaxis
KW  - Lung transplantation
KW  - Antiviral agents
KW  - Clinical trials, phase III as topic
KW  - Combined modality therapy
KW  - Cytomegalovirus
KW  - Cytomegalovirus infections
KW  - Equivalence trials as topic
KW  - Humans
KW  - Immunity, cellular
KW  - Lung transplantation
KW  - Multicenter studies as topic
KW  - Postoperative complications
KW  - Premedication
KW  - Randomized controlled trials as topic
KW  - Time factors
KW  - Treatment outcome
TI  - Efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis to prevent cytomegalovirus disease in lung transplant recipients (CYTOCOR STUDY): an open-label, randomised, non-inferiority clinical trial.
TY  - research article
VL  - 9
ER  -